Study of Two Digital Therapeutics for the Prevention of Episodic Migraine

NACompletedINTERVENTIONAL
Enrollment

568

Participants

Timeline

Start Date

March 28, 2023

Primary Completion Date

May 7, 2024

Study Completion Date

May 7, 2024

Conditions
MigraineEpisodic MigraineHeadacheHeadache, Migraine
Interventions
DEVICE

ReMMi-D Digital Therapeutic

Evaluate the effectiveness and safety of prescription mobile applications that provide an interactive, software-based intervention for the preventative treatment of episodic migraine in late adults and adolescents.

Trial Locations (1)

10013

Click Therapeutics, New York

Sponsors
All Listed Sponsors
lead

Click Therapeutics, Inc.

INDUSTRY